UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

Treatment with a Lactococcus lactis that chromosomally express E. coli cfaI mitigates salivary flow loss in a Sjögren's syndrome-like disease

Scientific reports, 2023-11, Vol.13 (1), p.19489-19489, Article 19489

2023

Volltextzugriff (PDF)

Dendritic cell PAR1-S1P3 signalling couples coagulation and inflammation

Nature, 2008-04, Vol.452 (7187), p.654-658

2008

Volltextzugriff (PDF)

1140 – Syn-007, an Oral Beta-Lactamase Prevents Gut Microbime Dysbiosis Caused by Oral Amoxicillin and Oral Amoxicillin/Clavulanate Without Affecting Amoxicillin Systemic Absorption in Dogs

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-241-S-242

2019

Volltextzugriff (PDF)

Sa1839 - Orally Delivered Beta-Lactamase Prevents Gut Microbiome Dysbiosis Caused by IV and Oral Antibiotics and Mitigates Propagation of Antibiotic Resistance in Porcine and Canine Models

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.S-415-S-415

2018

Volltextzugriff (PDF)

332g - An Orally Delivered Beta-Lactamase Protects the Gut Microbiome from Antibiotic-Mediated Damage and Mitigates the Propagation of Antibiotic-Resistance Genes in a Porcine Dysbiosis Model

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S1305-S1306

2017

Volltextzugriff (PDF)

An Orally Delivered Beta-Lactamase Protects the Gut Microbiome from Antibiotic-Mediated Damage and Mitigates the Propagation of Antibiotic-Resistance Genes in a Porcine Dysbiosis Model

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S1305-S1306

2017

Volltextzugriff (PDF)

673. Novel Delayed-Release Formulation of an Oral β-Lactamase Prevents Gut Microbiome Damage and Attenuates Antibiotic Resistance Caused by Oral Amoxicillin/Clavulanate without Interfering with Amoxicillin Systemic Absorption in Dogs

Open forum infectious diseases, 2019-10, Vol.6 (Supplement_2), p.S307-S307

2019

Volltextzugriff (PDF)

A Crucial Role for Caspase 1 in Thrombo-Inflammatory Microparticle Release

Blood, 2014-12, Vol.124 (21), p.2806-2806

2014

Volltextzugriff (PDF)

620. Oral β-Lactamase Therapies Prevent Microbiome Damage and Attenuate Antibiotic Resistance From IV and Oral Antibiotics in Large Animal Models of Antibiotic-Mediated Gut Dysbiosis

Open forum infectious diseases, 2018-11, Vol.5 (suppl_1), p.S226-S226

2018

Volltextzugriff (PDF)

Inflammation, Obesity, and Thrombosis

Blood, 2012-11, Vol.120 (21), p.SCI-45-SCI-45

2012

Volltextzugriff (PDF)

SYN-006, a Novel Carbapenemase, Intended to Protect the Gut Microbiome from Antibiotic-Mediated Damage May Also Reduce Propagation of Carbapenem-Resistant Pathogens

Open forum infectious diseases, 2017-10, Vol.4 (suppl_1), p.S231-S232

2017

Volltextzugriff (PDF)

Gut Antibiotic Inactivation by Β-Lactamases Is Intended to Prevent Microbiome Damage and Attenuate Antibiotic Resistance in Large Animal Models

Open forum infectious diseases, 2017-10, Vol.4 (suppl_1), p.S232-S233

2017

Volltextzugriff (PDF)

Thrombosis and Inflammation Are Coupled by a Common Thioredoxin Reductase Pathway Downstream of the P2×7 Receptor

Blood, 2012-11, Vol.120 (21), p.2218-2218

2012

Volltextzugriff (PDF)

Protease-Activated Receptor 4 (PAR4) Plays a Critical Role in Fetal Loss and Peripheral Thrombosis in a Mouse Model of Thrombophilia

Blood, 2011-11, Vol.118 (21), p.373-373

2011

Volltextzugriff (PDF)

Tissue factor-PAR2 signaling promotes diet-induced obesity and adipose inflammation

Nature medicine, 2011-10, Vol.17 (11), p.1490-1497

2011

Volltextzugriff (PDF)

P2X7 receptor signaling contributes to tissue factor-dependent thrombosis in mice

The Journal of clinical investigation, 2011-07, Vol.121 (7), p.2932

2011

Volltextzugriff (PDF)

P2×7 Signaling Triggers Tissue Factor Activation and Protein Disulfide Isomerase-Dependent Release of TF+ Microparticles In Thrombosis

Blood, 2010-11, Vol.116 (21), p.344-344

2010

Volltextzugriff (PDF)

Novel Infrared Fluorescence Methodology Defines An Essential Role for Endothelial Protein C Receptor (EPCR) for Protection Against Vascular Leakage In Inflammation

Blood, 2010-11, Vol.116 (21), p.653-653

2010

Volltextzugriff (PDF)

Clinical-Stage, Oral β-Lactamase Enzyme to Prevent Clostridium difficile Infection Triggered by Antibiotic-Mediated Gut Microbiome Disruption

Open forum infectious diseases, 2016-12, Vol.3 (suppl_1)

2016

Volltextzugriff (PDF)

Differences in the Anticoagulant Activity of Murine and Human Activated Protein C (APC) in Mouse Thrombosis Models

Blood, 2006-11, Vol.108 (11), p.1471-1471

2006

Volltextzugriff (PDF)

Successful Production of Canine FVIII: Biochemical and Functional Characterization in Hemophilia A Dogs

Blood, 2007-11, Vol.110 (11), p.495-495

2007

Volltextzugriff (PDF)

Protease−Activated Receptor 2 (PAR−2) as a Novel Target To Prevent Inhibitor Formation to FIX

Blood, 2006-11, Vol.108 (11), p.763-763

2006

Volltextzugriff (PDF)

Protease-Activated Receptor-2 (PAR-2) as a Novel Target for Modulating Immune Responses to Neo Antigens Following In Vivo Gene Transfer

Blood, 2005-11, Vol.106 (11), p.1296-1296

2005

Volltextzugriff (PDF)

Assessing the Role of Continuous Activated Protein C (APC) Expression in Murine Thrombosis Models

Blood, 2005-11, Vol.106 (11), p.1030-1030

2005

Volltextzugriff (PDF)

Co-Inheritance of FV Leiden and High Levels of FIX Results in Novel Models for Thrombophilia and Spontaneous Fetal Loss

Blood, 2005-11, Vol.106 (11), p.1946-1946

2005

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(29)

Sprache

Englisch
(29)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(13)
Open Forum Infectious Diseases
(5)
Gastroenterology
(4)
Molecular Therapy
(3)
Nature
(1)
Nature Medicine
(1)
Scientific Reports
(1)
The Journal Of Clinical Investigation
(1)

3 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Treatment with a Lactococcus lactis that chromosomally express E. coli cfaI mitigates salivary flow loss in a Sjögren's syndrome-like disease

Dendritic cell PAR1-S1P3 signalling couples coagulation and inflammation

1140 – Syn-007, an Oral Beta-Lactamase Prevents Gut Microbime Dysbiosis Caused by Oral Amoxicillin and Oral Amoxicillin/Clavulanate Without Affecting Amoxicillin Systemic Absorption in Dogs

Sa1839 - Orally Delivered Beta-Lactamase Prevents Gut Microbiome Dysbiosis Caused by IV and Oral Antibiotics and Mitigates Propagation of Antibiotic Resistance in Porcine and Canine Models

332g - An Orally Delivered Beta-Lactamase Protects the Gut Microbiome from Antibiotic-Mediated Damage and Mitigates the Propagation of Antibiotic-Resistance Genes in a Porcine Dysbiosis Model

An Orally Delivered Beta-Lactamase Protects the Gut Microbiome from Antibiotic-Mediated Damage and Mitigates the Propagation of Antibiotic-Resistance Genes in a Porcine Dysbiosis Model

673. Novel Delayed-Release Formulation of an Oral β-Lactamase Prevents Gut Microbiome Damage and Attenuates Antibiotic Resistance Caused by Oral Amoxicillin/Clavulanate without Interfering with Amoxicillin Systemic Absorption in Dogs

A Crucial Role for Caspase 1 in Thrombo-Inflammatory Microparticle Release

620. Oral β-Lactamase Therapies Prevent Microbiome Damage and Attenuate Antibiotic Resistance From IV and Oral Antibiotics in Large Animal Models of Antibiotic-Mediated Gut Dysbiosis

Inflammation, Obesity, and Thrombosis

SYN-006, a Novel Carbapenemase, Intended to Protect the Gut Microbiome from Antibiotic-Mediated Damage May Also Reduce Propagation of Carbapenem-Resistant Pathogens

Gut Antibiotic Inactivation by Β-Lactamases Is Intended to Prevent Microbiome Damage and Attenuate Antibiotic Resistance in Large Animal Models

Thrombosis and Inflammation Are Coupled by a Common Thioredoxin Reductase Pathway Downstream of the P2×7 Receptor

Protease-Activated Receptor 4 (PAR4) Plays a Critical Role in Fetal Loss and Peripheral Thrombosis in a Mouse Model of Thrombophilia

Tissue factor-PAR2 signaling promotes diet-induced obesity and adipose inflammation

P2X7 receptor signaling contributes to tissue factor-dependent thrombosis in mice

P2×7 Signaling Triggers Tissue Factor Activation and Protein Disulfide Isomerase-Dependent Release of TF+ Microparticles In Thrombosis

Novel Infrared Fluorescence Methodology Defines An Essential Role for Endothelial Protein C Receptor (EPCR) for Protection Against Vascular Leakage In Inflammation

Clinical-Stage, Oral β-Lactamase Enzyme to Prevent Clostridium difficile Infection Triggered by Antibiotic-Mediated Gut Microbiome Disruption

Differences in the Anticoagulant Activity of Murine and Human Activated Protein C (APC) in Mouse Thrombosis Models

Successful Production of Canine FVIII: Biochemical and Functional Characterization in Hemophilia A Dogs

Protease−Activated Receptor 2 (PAR−2) as a Novel Target To Prevent Inhibitor Formation to FIX

Protease-Activated Receptor-2 (PAR-2) as a Novel Target for Modulating Immune Responses to Neo Antigens Following In Vivo Gene Transfer

Assessing the Role of Continuous Activated Protein C (APC) Expression in Murine Thrombosis Models

Co-Inheritance of FV Leiden and High Levels of FIX Results in Novel Models for Thrombophilia and Spontaneous Fetal Loss

Aktive Filter

Suchergebnisse filtern